Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for immunoconjugate (compound)
Most Correlated Studies
- Germinal B cells from spleen of systemic lupus erythematosus mice treated with CTLA4Ig & anti-CD40L
- Whole blood of rheumatoid arthritis patients treated with abatacept
- CD4-positive T cells and antigen presenting cells from OVA TCR mice treated with abatacept
- T-cells expression after treatment with leukocyte costimulatory blockade antibodies
- Drug target sets for approved compounds
Most Relevant Literature
- Designing immunoconjugates for cancer therapy.
- Immunoconjugates and long circulating systems: origins, current state of the art and future directio…
- Tailored immunoconjugate therapy depending on a quantity of tumor stroma.
- Risks and untoward toxicities of antibody-based immunoconjugates.
- Immunoconjugates against solid tumors: mind the gap.
Most Relevant Clinical Trials
- ItaliaN Observational Study of Patients With Acute Lymphoblastic Leukemia Treated With Anti-CD22 Imm…
- A Phase I/II Open-Label, Non-Randomized Dose Escalation Study of Immunoconjugate L-DOS47
- Safety/Efficacy Study of Immunoconjugate With Docetaxel in Non-small Cell Lung Carcinoma
- Monoclonal Antibody Therapy in Treating Patients With Recurrent Acute Lymphoblastic Leukemia or Non-…
- Expanded Access Request Program for Belantamab Mafodotin (GSK2857916) in Multiple Myeloma
